Cargando…
Next-Generation Antimalarial Drugs: Hybrid Molecules as a New Strategy in Drug Design
Malaria is a disease that affects nearly 40% of the global population, and chemotherapy remains the mainstay of its control strategy. The global malaria situation is increasingly being exacerbated by the emergence of drug resistance to most of the available antimalarials, necessitating search for no...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Wiley Subscription Services, Inc., A Wiley Company
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049227/ https://www.ncbi.nlm.nih.gov/pubmed/21399701 http://dx.doi.org/10.1002/ddr.20345 |